Euflexxa inj per dose
Products billed under this code include Euflexxa.
Payment limit per per dose, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Euflexxa.
Payment limit per per dose, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Euflexxa | Ferring Pharmaceuticals Inc. | 55566-4100-01 | 3 | $310.809 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $103.603 | +$5.466 | per dose | Euflexxa inj per dose | v1, posted September 17, 2026 |
| 3Q26 | $98.137 | −$7.443 | per dose | Euflexxa inj per dose | v1, posted September 15, 2026 |
| 2Q26 | $105.58 | +$0.116 | per dose | Euflexxa inj per dose | v1, posted September 15, 2026 |
| 1Q26 | $105.464 | −$6.99 | per dose | Euflexxa inj per dose | v1, posted September 15, 2026 |
| 4Q25 | $112.454 | −$2.028 | per dose | Euflexxa inj per dose | v1, posted September 8, 2026 |
| 3Q25 | $114.482 | −$11.927 | per dose | Euflexxa inj per dose | v1, posted March 10, 2026 |
| 2Q25 | $126.409 | +$6.457 | per dose | Euflexxa inj per dose | v1, posted March 10, 2026 |
| 1Q25 | $119.952 | −$1.36 | per dose | Euflexxa inj per dose | v1, posted December 19, 2025 |
| 4Q24 | $121.312 | −$0.667 | per dose | Euflexxa inj per dose | v1, posted June 11, 2025 |
| 3Q24 | $121.979 | +$6.406 | per dose | Euflexxa inj per dose | v1, posted June 11, 2025 |
| 2Q24 | $115.573 | −$11.727 | per dose | Euflexxa inj per dose | v1, posted March 11, 2025 |
| 1Q24 | $127.30 | +$4.158 | per dose | Euflexxa inj per dose | v1, posted December 19, 2024 |
| 4Q23 | $123.142 | −$8.278 | per dose | Euflexxa inj per dose | v1, posted October 10, 2024 |
| 3Q23 | $131.42 | +$1.955 | per dose | Euflexxa inj per dose | v1, posted June 5, 2024 |
| 2Q23 | $129.465 | −$0.118 | per dose | Euflexxa inj per dose | v1, posted February 23, 2024 |
| 1Q23 | $129.583 | −$1.303 | per dose | Euflexxa inj per dose | v1, posted December 6, 2023 |
| 4Q22 | $130.886 | −$0.147 | per dose | Euflexxa inj per dose | v1, posted June 22, 2023 |
| 3Q22 | $131.033 | −$0.173 | per dose | Euflexxa inj per dose | v1, posted June 9, 2023 |
| 2Q22 | $131.206 | −$4.029 | per dose | Euflexxa inj per dose | v1, posted December 14, 2022 |
| 1Q22 | $135.235 | −$3.583 | per dose | Euflexxa inj per dose | v1, posted June 8, 2022 |
| 4Q21 | $138.818 | +$9.656 | per dose | Euflexxa inj per dose | v1, posted June 2, 2022 |
| 3Q21 | $129.162 | −$9.369 | per dose | Euflexxa inj per dose | v1, posted June 2, 2022 |
| 2Q21 | $138.531 | +$3.392 | per dose | Euflexxa inj per dose | v1, posted March 1, 2022 |
| 1Q21 | $135.139 | – | per dose | Euflexxa inj per dose | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.